Cefuroxime USP with Clavulanic Acid USP
Composition : (CefuroximeUSP 125 mg + Clavulanic Acid USP 31.25 mg)/5ml Suspension.
Indication :It is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below : Pharyngitis/tonsillitis, Acute bacterial otitis media, Acute bacterial maxillary sinusitis, Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis, Uncomplicated skin and skin-structure infections, Uncomplicated urinary tract infections, Uncomplicated gonorrhea, Early lyme disease.
Dosage and administration : Please see prescribing description for more information.
Packing :
Fuclav suspension : 70 ml suspension.
